European Association for the Study of Liver (EASL) Congress 2026

Topics

• Alcohol-related liver disease
• Acute liver failure and drug induced liver injury
• Cirrhosis and its complications: Other clinical complications except ACLF and critical illness
• Cirrhosis and its complications: ACLF and Critical illness
• Immune-mediated and cholestatic disease: Clinical aspects
• Cirrhosis and its complications: Portal Hypertension
• Liver tumours: Clinical aspects except therapy
• Liver transplantation and hepatobiliary surgery
• NAFLD: Clinical aspects except therapy
• Liver tumours: Therapy
• NAFLD: Therapy
• NAFLD: Diagnostics and non-invasive assessment
• Rare liver diseases (including paediatric and genetic)
• Non-invasive assessment of liver disease except NAFLD
• Viral hepatitis B and D: Clinical aspects
• Viral hepatitis A/E: Clinical aspects
• Viral Hepatitis B and D: New therapies, unapproved therapies or strategies
• Viral Hepatitis B and D: Current therapies
• Viral hepatitis C: Therapy and resistance
• Viral Hepatitis C: Clinical aspects including follow up after SVR
• Alcohol-related liver disease
• Acute liver failure and drug induced liver injury
• Fibrosis / Stellate cell biology
• Cirrhosis and its complications: Experimental and pathophysiology
• Hepatocyte biology
• Gut microbiota and liver disease / Liver-organ crosstalk
• Liver development and regeneration
• Immune-mediated and cholestatic: Experimental and pathophysiology
• Liver transplantation and hepatobiliary surgery
• Liver immunology
• NAFLD: Experimental and pathophysiology
• Liver tumours: Experimental and pathophysiology
• Viral Hepatitis: Experimental and pathophysiology
• Rare liver diseases (including paediatric and genetic)

Who should Attend

Specialists in the fields of Liver Cancer, Hepatology, Pediatric Hepatology, Liver Transplantation, Internal Medicine, Basic Science, Infectious Diseases, Cell Biology, Pharmacology, Microbiology/Virology, Radiology/Imaging, Pathology and Gastroenterology.